Clinical Trials

Showing trials with last updates posted in 2026.

NCT05112601 | RECRUITING | PHASE2
81 participants

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2022-06-02
Completion:
2032-07-30
Conditions
  • Endometrial Adenocarcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Mucinous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Endometrioid Adenocarcinoma
  • Recurrent Endometrial Carcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT05013450 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
33 participants

Dupilumab_Metastatic NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2021-09-10
Completion:
2025-09-18
Conditions
  • Metastatic Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT04877288 | RECRUITING | PHASE3
102 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page